FDA NDC Directory · JSON-LD · Markdown

Topiramate

NDC 67877-796 · HUMAN PRESCRIPTION DRUG · CAPSULE, EXTENDED RELEASE

Labeler / ManufacturerAscend Laboratories, LLC
Marketing categoryAbbreviated NDA (generic) · App ANDA217248
Dosage form / routeCAPSULE, EXTENDED RELEASE · ORAL
Active ingredientsTOPIRAMATE (200 mg/1)
Marketing started20261015
Package count4

External sources

Source: openFDA. Public-domain (CC0).